Next Fundraisers
- Golf Tourney, NH, 5/25/12
- Patrick's Pals, MA, 6/2/12
- Cruise-In, PA 6/3/12
How to Donate
You can help us find a cure
for Fragile X!
What is Fragile X?
Fragile X is the most common inherited cause of mental impairment and the most common known cause of autism.
About FRAXA
FRAXA is a 501c3 nonprofit run by parents. Our mission: to find treatments and a cure for Fragile X. FRAXA has funded over $20 million in research.
Clinical Trials Happening
Now - Volunteers Needed
Email Signup
Get the latest FRAXA News!

April 16, 2012

Clinical trials of three experimental new treatments for Fragile X are accepting participants
slides from today's FRAXA Webinar
There are active trials with two different mGluR5 antagonists - one from Novartis, the other from Roche - and arbaclofen from Seaside Therapeutics - in large scale trials.

read more >

April 11, 2012

Fragile X syndrome reversed in adult mice
A new study used used a compound that inhibits mGluR5 to correct signs of Fragile X. The work was done by a team led by Dr. Lothar Lindemann at Roche, and a group led by Dr. Mark Bear at MIT.

read more >

April 03, 2012

FRAXA Announces 2012 Fragile X Research Awards
$1,132,923 in New Program Grants, Postdoctoral Fellowships, and Renewals have been approved. We are funding over $846,000 in new projects; renewals total $285,678 and will increase as additional projects reach their one year mark.

read more >

March 21, 2012

Knockout Rat Model for Fragile X: shipping 4/2/12
Genetically engineered Fragile X Knockout mice will give scientists a new key to understanding Fragile X.

read more >